StockData
Tandem Diabetes Care Inc logo

Tandem Diabetes Care Inc (TNDM) stock

TNDMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3030% below fair value
$17.05−0.01 (-0.06%)

Close on Nov 18, 2026Market cap $1.19BP/E –Yield –

Tandem Diabetes Care operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Tandem Diabetes Care's operating cash flow for the twelve months ending Jun 30, 2026 was -$5.52M, down 156.8% year over year. For fiscal 2025 it was -$9.72M, down 140.1% from the year before. The highest annual figure on record is $111.36M in fiscal 2021.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$9.72M-140.1%
FY2024Dec 31, 2024$24.23M–
FY2023Dec 31, 2023-$31.81M-163.0%
FY2022Dec 31, 2022$50.46M-54.7%
FY2021Dec 31, 2021$111.36M+351.4%
FY2020Dec 31, 2020$24.67M-41.1%
FY2019Dec 31, 2019$41.91M–
FY2018Dec 31, 2018-$8.32M–
FY2017Dec 31, 2017-$66.14M–
FY2016Dec 31, 2016-$61.17M–
FY2015Dec 31, 2015-$58.76M–
FY2014Dec 31, 2014-$61.38M–
FY2013Dec 31, 2013-$47.76M–
FY2012Dec 31, 2012-$33.47M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$34.63M–
Q1 FY2026Mar 31, 2026$11.05M–
Q4 FY2025Dec 31, 2025$9.79M-8.7%
Q3 FY2025Sep 30, 2025$8.26M-69.1%
Q2 FY2025Jun 30, 2025-$9.50M–
Q1 FY2025Mar 31, 2025-$18.28M–
Q4 FY2024Dec 31, 2024$10.72M–
Q3 FY2024Sep 30, 2024$26.78M+48589.1%
Q2 FY2024Jun 30, 2024-$5.28M–
Q1 FY2024Mar 31, 2024-$8.00M–
Q4 FY2023Dec 31, 2023-$7.22M-224.0%
Q3 FY2023Sep 30, 2023$55.00K-99.8%
Q2 FY2023Jun 30, 2023-$6.32M-191.6%
Q1 FY2023Mar 31, 2023-$18.33M-232.8%
Q4 FY2022Dec 31, 2022$5.82M-70.4%
Q3 FY2022Sep 30, 2022$23.94M-29.9%
Q2 FY2022Jun 30, 2022$6.90M-76.1%
Q1 FY2022Mar 31, 2022$13.80M-51.9%
Q4 FY2021Dec 31, 2021$19.64M+28.9%
Q3 FY2021Sep 30, 2021$34.14M+134.4%
Q2 FY2021Jun 30, 2021$28.90M+86.4%
Q1 FY2021Mar 31, 2021$28.69M–
Q4 FY2020Dec 31, 2020$15.24M-21.6%
Q3 FY2020Sep 30, 2020$14.56M-36.7%
Q2 FY2020Jun 30, 2020$15.50M+334.4%
Q1 FY2020Mar 31, 2020-$20.63M–
Q4 FY2019Dec 31, 2019$19.44M+37.6%
Q3 FY2019Sep 30, 2019$23.02M–
Q2 FY2019Jun 30, 2019$3.57M–
Q1 FY2019Mar 31, 2019-$4.12M–
Q4 FY2018Dec 31, 2018$14.13M–
Q3 FY2018Sep 30, 2018-$3.46M–
Q2 FY2018Jun 30, 2018-$6.72M–
Q1 FY2018Mar 31, 2018-$12.27M–
Q4 FY2017Dec 31, 2017-$11.64M–
Q3 FY2017Sep 30, 2017-$19.02M–
Q2 FY2017Jun 30, 2017-$14.67M–
Q1 FY2017Mar 31, 2017-$20.81M–
Q4 FY2016Dec 31, 2016-$13.58M–
Q3 FY2016Sep 30, 2016-$18.15M–

More Tandem Diabetes Care figures

See a number that looks wrong?